microrx
Our platform allows us to rapidly select gut bacteria which have a therapeutic effect in specific diseases
pipeline
We have a broad and deep pipeline of live biotherapeutics, with programmes spanning GI, immuno-oncology, respiratory, autoimmune and CNS
IP
4D has a sector-leading patent estate with more than 40 granted patents globally

BACK TO TOP